Home | Business News | Browse by Publication | M | M2 Presswire

While Alliance Pharmaceutical Provides Update on Product Development, Other Companies Report Financial Results, Make Investor Conference Presentations, Elaborate on Mergers and Provide Sales Figures.

Publication: M2 Presswire
Publication Date: 20-OCT-06
Format: Online
Delivery: Immediate Online Access

Article Excerpt
M2 PRESSWIRE-20 October 2006-Stockguru.com: While Alliance Pharmaceutical Provides Update on Product Development, Other Companies Report Financial Results, Make Investor Conference Presentations, Elaborate on Mergers and Provide Sales Figures(C)1994-2006 M2 COMMUNICATIONS LTD

RDATE:20102006

Dallas, Texas - StockGuru Pre-Market Updates for Friday include Alliance Pharmaceutical Corp. (OTCBB: ALLP), IGIA, Inc., (OTCBB: IGAI ), EAU Technologies, Inc.(OTCBB:EAQU), MRU Holdings, Inc. (OTCBB: UNCL), EarthFirst Technologies, Inc. (OTCBB:EFTI), and Sono-Tek Corporation (OTCBB: SOTK). StockGuru Pre-Market Updates feature companies with significant moves in either volume or price in the past two trading sessions. In our update we analyze recent news about the companies featured and detail the movement in the stock.

If you would like to feature your publicly traded company in our alerts or on StockGuru.com, email feature@stockguru.com or call (469)252-3031.

Alliance Pharmaceutical Corp. (OTCBB: ALLP) - Thursday's shares stayed even at $0.120. The volume was at 16,524. Alliance Pharmaceutical Corp. announces the following update with regard to the development of Oxygent(TM) (perfluorochemical (PFC) emulsion) to prevent post-op ileus resulting from hypoxia during major surgery. Earlier this year, Alliance applied to the Competent Authorities and to the Ethics Committees (equivalent to Investigational Review Board [IRB] in the U.S.) in France and Germany to proceed with the start of a Phase 2 Proof of Concept clinical trial. The objective of the study will be to show the safety and demonstrate the efficacy of Oxygent to improve post-op gut function. The study is expected to enroll approximately 65 patients.

Alliance Pharmaceutical Corp., founded in 1989, is a development-stage pharmaceutical company that is currently focused on developing its lead product, Oxygent, which is based on its proprietary PFC technology. Oxygent is being developed as an intravascular oxygen carrier designed to augment oxygen delivery in surgical patients.

For a quote and the...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from M2 Presswire
HTVL, MRKL, SWME, FCCN, RPTN, PFEH Are Crossing Above Their SqueezeTri..., October 20, 2006
ESWW, PMED, ADSPQ, BOAI, BREK, CYHD Are Crossing Above Their SqueezeTr..., October 20, 2006
Issues Updates of Given Imaging Ltd., October 20, 2006
Bellwether Report.com is Scouting Unisys Corp., October 20, 2006
Bellwether Report.com is Tracking Given Imaging Ltd., October 20, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.